MyFinsight
Home
Blog
About
Contact
Back
Income Statement
Xilio Therapeutics, Inc. (XLO)
Xilio Therapeutics, Inc. (XLO)
source: myfinsight.com
Download
Download image
Change in fair value of
common stock warrant...
-$3,300K
Other income, net
$1,283K
(118.94%↑ Y/Y)
Net gain and
comprehensive gain
-$9,529K
(28.16%↑ Y/Y)
Total other income,
net
$4,583K
(682.08%↑ Y/Y)
Loss from operations
-$14,112K
(-1.88%↓ Y/Y)
Total revenue
$12,648K
(331.67%↑ Y/Y)
Total operating
expenses
$26,760K
(59.47%↑ Y/Y)
Research and development
$19,832K
(139.92%↑ Y/Y)
General and
administrative
$6,928K
(-18.64%↓ Y/Y)
Back